Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
CASI
CASI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest CASI ETF News Today | Earnings, Events & Price Alerts
CASI News
CASI Pharmaceuticals to Be Delisted from Nasdaq
6d ago
NASDAQ.COM
CASI Pharmaceuticals Plans Transition to OTC Markets After Nasdaq Delisting
6d ago
Benzinga
U.S. Stocks Rise as TJX Reports Strong Earnings Beat
6d ago
Benzinga
CASI Pharmaceuticals Faces Nasdaq Delisting Decision
Feb 25 2026
stocktwits
U.S. Stocks Rise in Morning Trading, Dow Jones Up Over 200 Points
Feb 25 2026
Benzinga
CASI PHARMACEUTICALS ANTICIPATES LISTING OF ORDINARY SHARES ON OTC MARKET RUN BY OTC MARKETS GROUP INC.
Feb 25 2026
moomoo
CASI Pharmaceuticals Obtains Delisting Decision from NASDAQ Hearings Panel
Feb 25 2026
moomoo
CASI Pharmaceuticals Faces Nasdaq Delisting
Feb 25 2026
seekingalpha
Dayforce Shares Surge Approximately 21%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 18 2025
Benzinga
Premarket Stock Movements: PPCB, BTAI, TNXP, DAY, TPIC, and Other Notable Gainers and Losers
Aug 18 2025
NASDAQ.COM
Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates
Aug 12 2025
NASDAQ.COM
HC Wainwright & Co. Reiterates Buy on CASI Pharmaceuticals, Maintains $4 Price Target
May 19 2025
Benzinga
CASI Pharma Receives New $20 Mln Buyout Proposal For China Unit And Drug Rights
Apr 01 2025
NASDAQ.COM
Casi Pharmaceuticals files $200M mixed securities shelf
Dec 20 2024
Business Insider
Novartis expands U.S. radiopharma production (NYSE:NVS)
Sep 04 2024
SeekingAlpha
CASI Stock Earnings: CASI Pharmaceuticals Beats EPS, Misses Revenue for Q2 2024
Aug 16 2024
Business Insider
Show More News
